AFFIDX Trademark

Trademark Overview


On Tuesday, September 22, 2020, a trademark application was filed for AFFIDX with the United States Patent and Trademark Office. The USPTO has given the AFFIDX trademark a serial number of 79304130. The federal status of this trademark filing is REGISTERED as of Tuesday, August 30, 2022. This trademark is owned by Avacta Limited. The AFFIDX trademark is filed in the Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Medical Instrument Products, and Medical & Beauty Services & Agricultural Services categories with the following description:

Downloadable software in the nature of mobile application software for medical diagnostics; Downloadable software in the nature of mobile application software for the collection, analysis and reporting of diagnostic tests; downloadable mobile application software for the collection, analysis and reporting of diagnostic tests for Covid-19 and influenza

Diagnostic testing materials, namely diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing, medical diagnostic reagents and assays for testing of body fluids, diagnostic agents, preparations and substances for medical purposes; diagnostic materials being diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing, medical diagnostic reagents and assays for testing of body fluids, diagnostic agents, preparations and substances for medical purposes, preparations for medical testing purposes and test strips for medical testing purposes namely for testing for the detection and diagnosis of covid-19 and influenza; diagnostic materials being diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing, medical diagnostic reagents and assays for testing of body fluids, diagnostic agents, preparations and substances for medical purpose...

Medical diagnostic testing being medical testing for diagnostic or treatment purposes, and analysis services namely medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical testing being medical testing for diagnostic or treatment purposes, and analysis services namely medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical diagnostic testing being medical testing for diagnostic or treatment purposes, and analysis services namely medical analysis services for diagnostic and treatment purposes provided by medical laboratories for covid-19 and influenza; medical testing being medical testing for diagnostic or treatment purposes and analysis services namely medical analysis services for diagnostic and treatment purposes provided by medical laboratories for covid-19 and influenza; advisory and information services relating to all the aforesaid

Medical testing apparatus, instruments and equipment for diagnostic use namely apparatus for medical diagnostic testing for the detection and diagnosis of covid-19 and influenza; medical testing apparatus, instruments and equipment for the detection and diagnosis of Covid-19 and influenza, namely medical diagnostic apparatus for testing for viruses, medical diagnostic instruments for the analysis of body fluids, apparatus for virus testing purposes
affidx

General Information


Serial Number79304130
Word MarkAFFIDX
Filing DateTuesday, September 22, 2020
Status700 - REGISTERED
Status DateTuesday, August 30, 2022
Registration Number6829613
Registration DateTuesday, August 30, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 14, 2022

Trademark Statements


Goods and ServicesDownloadable software in the nature of mobile application software for medical diagnostics; Downloadable software in the nature of mobile application software for the collection, analysis and reporting of diagnostic tests; downloadable mobile application software for the collection, analysis and reporting of diagnostic tests for Covid-19 and influenza
Goods and ServicesDiagnostic testing materials, namely diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing, medical diagnostic reagents and assays for testing of body fluids, diagnostic agents, preparations and substances for medical purposes; diagnostic materials being diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing, medical diagnostic reagents and assays for testing of body fluids, diagnostic agents, preparations and substances for medical purposes, preparations for medical testing purposes and test strips for medical testing purposes namely for testing for the detection and diagnosis of covid-19 and influenza; diagnostic materials being diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing, medical diagnostic reagents and assays for testing of body fluids, diagnostic agents, preparations and substances for medical purposes, preparations for medical testing purposes and test strips for lateral flow medical testing purposes namely for the detection and diagnosis of covid-19 and influenza; diagnostic reagents for medical purposes; diagnostic testing materials being diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing, medical diagnostic reagents and assays for testing of body fluids, diagnostic agents, preparations and substances for medical purposes for the detection and diagnosis of covid-19 and influenza; diagnostic preparations for medical testing purposes; materials namely diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing, medical diagnostic reagents and assays for testing of body fluids, diagnostic agents, preparations and substances for medical purposes, and medical diagnostic strips for lateral flow medical testing purposes namely for the detection and diagnosis of covid-19 and influenza, and diagnostic reagents for medical testing purposes, all for the detection and diagnosis of covid-19 and influenza
Goods and ServicesMedical diagnostic testing being medical testing for diagnostic or treatment purposes, and analysis services namely medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical testing being medical testing for diagnostic or treatment purposes, and analysis services namely medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical diagnostic testing being medical testing for diagnostic or treatment purposes, and analysis services namely medical analysis services for diagnostic and treatment purposes provided by medical laboratories for covid-19 and influenza; medical testing being medical testing for diagnostic or treatment purposes and analysis services namely medical analysis services for diagnostic and treatment purposes provided by medical laboratories for covid-19 and influenza; advisory and information services relating to all the aforesaid
Goods and ServicesMedical testing apparatus, instruments and equipment for diagnostic use namely apparatus for medical diagnostic testing for the detection and diagnosis of covid-19 and influenza; medical testing apparatus, instruments and equipment for the detection and diagnosis of Covid-19 and influenza, namely medical diagnostic apparatus for testing for viruses, medical diagnostic instruments for the analysis of body fluids, apparatus for virus testing purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 12, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateFriday, February 12, 2021
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, February 12, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, February 12, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAvacta Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameAvacta Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameAvacta Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, February 11, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, February 12, 2021ASSIGNED TO EXAMINER
Monday, March 15, 2021REFUSAL PROCESSED BY IB
Wednesday, August 4, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 12, 2021NON-FINAL ACTION WRITTEN
Saturday, February 13, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, February 16, 2021APPLICATION FILING RECEIPT MAILED
Monday, February 22, 2021REFUSAL PROCESSED BY MPU
Monday, February 22, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, August 4, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 4, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 18, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, May 9, 2022NON-FINAL ACTION E-MAILED
Tuesday, August 31, 2021LETTER OF SUSPENSION E-MAILED
Tuesday, August 31, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, August 31, 2021SUSPENSION LETTER WRITTEN
Monday, April 18, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 18, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 2, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, May 9, 2022NON-FINAL ACTION WRITTEN
Monday, May 9, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 13, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Monday, August 1, 2022NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Monday, May 9, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 25, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 8, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, June 8, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, June 14, 2022PUBLISHED FOR OPPOSITION
Tuesday, June 14, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 5, 2022NOTIFICATION PROCESSED BY IB
Wednesday, July 13, 2022NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, December 7, 2022FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, July 1, 2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, August 30, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, August 30, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, November 30, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, December 7, 2022FINAL DISPOSITION PROCESSED
Wednesday, December 28, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, July 1, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 1, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 1, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 1, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, July 1, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 18, 2025NEW REPRESENTATIVE AT IB RECEIVED